Life quality in patients at terminal stage of chronic renal failure with no access to dialysis

: A transversal prospective study of 69 patients with terminal stage renal disease covering a 12 month period - 1st January to 31st December 2010 - was conducted; the objective was to determine factors affecting their quality of life. : This is a questionnaire study covering a 12 month period. The study group were patients with ESRD whose clearance of creatinin were less than 15ml/min. patients who died shortly after arrival, those with acute renal failure and those undergoing dialysis were excluded. : Soixante neufs patients ont ete retenus pour l'etude. Ils etaient 37 (53,6%) hommes et 32 (46,4%) femmes. L'âge moyen des hommes etait de 50,97 ± 2,91ans avec des extremes de 15 et 85 ans. L'âge moyen des femmes etait de 48 ± 3,13ans avec des extremes de 18 et 94 ans. Trente deux patients (46,3%) avaient une bonne qualite de vie et 37 (53,7%) avec une mauvaise qualite de vie. Dans ce dernier groupe l'âge moyen etait de 54 ± 4ans tandis que dans l'autre il etait de 47,6 ± 4ans (p=0,01). : Terminal stage renal disease represents 30.8% of admissions in 12 months, for a total of 69 patients. Thirty-two (46.3%) had good quality of life and 37 (53.7%) poor quality of life. In the latter group, the average age was of 54±4, while in the good quality of life group: the average age was 47.6 ± 4 (p=0.01). Patients in the good quality of life group had better health overall (OR=0.42). Poor quality of life patients had more severe pain (p=0.001); however good quality of life didn't protect against mental problems (p=0.866). Limitations due to mental status were more frequent at the poor quality of life (p=0.01). Social activities were more reduced in the poor quality of life group (p=0.0001) and there were more co-morbidities (29.7% with more than 4). : La meilleure qualite de vie est associee a l'âge plus jeune, peu de comorbidites, une faible douleur physique et des relations sociales conservees. Elle peut etre amelioree en agissant sur les facteurs modifiables tels que la meilleure prise en charge des comorbidites et de la douleur, une assistance sociale et professionnelle.